Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome.
1993 StandoutNobel
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels
1995
Treatment of Vascular Rejection With Rituximab in Cardiac Transplantation
2005
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
1994
Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
1996
Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants
1993
A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease
2008
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Delayed graft function in kidney transplantation
2004 Standout
Evaluation of the off‐label usage of rituximab in a large teaching hospital in New South Wales
2007
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
2007 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
A Review of Interleukin‐2 Receptor Antagonists in Solid Organ Transplantation
1999
Everolimus Therapeutic Concentration Range Defined from a Prospective Trial with Reduced-Exposure Cyclosporine in De Novo Kidney Transplantation
2004
Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α
1997 StandoutNobel
The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments
2006
Osmotic demyelination syndrome following rapid correction of hyponatraemia
2007
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1
2004
Malignancy in organ transplantation:
2002
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
2006
Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview
2006
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly
2001
Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis
2014
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency
2010
Minimizing Immunosuppression, an Alternative Approach to Reducing Side Effects
2008
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
2009
Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients
2005
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
2006 Standout
Perspectives in Organ Preservation
2007
Sirolimus May Reduce Fertility in Male Renal Transplant Recipients
2008
The CD5 B Cell
1989
Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens
2001
CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages
2012
Gene polymorphisms and transplantation
2001
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Cyclosporine: the principal immunosuppressant for renal transplantation
1998
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial
2001
Immunotherapy to reconstitute immunity to DNA viruses
2002
Clinical practice guideline on diagnosis and treatment of hyponatraemia
2014 Standout
REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2
1999
Posttransplant Erythrocytosis: An Enigma Revisited
1994
Use of Neoral C2 monitoring: a European consensus
2005
Screening for basiliximab exposure–response relationships in renal allotransplantation
1999
Xanthine oxidoreductase is central to the evolution and function of the innate immune system
2003 StandoutNobel
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Posttransplant erythrocytosis
2003
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Mammalian oxygen sensing and hypoxia inducible factor-1
1997 StandoutNobel
Monoclonal antibodies as therapeutic agents for cancer
2004
Hypoxia-Inducible Factor 1
1998 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sickle-cell disease
2010 Standout
Molecular biology of erythropoietin
1993 StandoutNobel
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2
1999
Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex which recognises mammalian HIF‐1 binding sites
1996 StandoutNobel
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1
1996 StandoutNobel
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
The Treatment of Hyponatremia
2009
Management of Chronic Allograft Nephropathy
2009
Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis
2012
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients
2012
Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature
2002
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder
2008
Effect of Angiotensin-Converting Enzyme Inhibitors on Response to Erythropoietin Therapy in Chronic Dialysis Patients
1998
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study
2005
Allogeneic bone marrow transplantation for active Epstein–Barr virus-related lymphoproliferative disease and hemophagocytic lymphohistiocytosis in an infant with severe combined immunodeficiency syndrome
2002
Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review
2010
Infection in Solid-Organ Transplant Recipients
2007 Standout
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
Effects of Enalapril on Erythrocytosis after Renal Transplantation
1991
The Physiology of Endothelial Xanthine Oxidase: From Urate Catabolism to Reperfusion Injury to Inflammatory Signal Transduction
2002
Sickle cell disease and the kidney
2008
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Urinary Creatinine Excretion Reflecting Muscle Mass is a Predictor of Mortality and Graft Loss in Renal Transplant Recipients
2008
Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept
2011
Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignancies
2005
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis
1998
Delayed graft function
2001
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid
2015
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases
2018 Standout
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
CD4+regulatory cells as a potential immunotherapy
2005 StandoutNobel
Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)
2006
Management of Epstein–Barr Virus-induced Post-transplant Lymphoproliferative Disease in Recipients of Solid Organ Transplantation
2001
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Transporter Associated with Antigen Processing**This article was accepted for publication on 1 October 1996.
1997
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.
1994 StandoutNobel
Diffuse large cell lymphoma
2011
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Post-Transplant Lymphoproliferative Disorders
2004
Long Term Effects of ACE Inhibitors on the Erythrocytosis in Renal Transplant Recipients
1995
Delayed graft function. Influence on outcome and strategies for prevention.
2001
Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
2005
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
1996 StandoutNobel
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
1999 StandoutNobel
Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.
1998
Diagnosis and Management of Posttransplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients
2001
Hidden Killers: Human Fungal Infections
2012 Standout
Oxygen Sensing, Hypoxia-Inducible Factor-1 and the Regulation of Mammalian Gene Expression
1998 StandoutNobel
Predictors of outcome in hospitalized patients with severe hyponatremia.
2003
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Works of B. Bourbigot being referenced
Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12
2003
Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids
2010
Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies
2004
Zygomycosis caused byCunninghamella bertholletiaein a kidney transplant recipient
2004
Captopril induces correction of postrenal transplant erythremia
1990
Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation
2005
Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study
2006
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
2006
Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab
2005
PROSPECTIVE RANDOMIZED COMPARISON OF UNIVERSITY OF WISCONSIN AND UW-MODIFIED, LACKING HYDROXYETHYL-STARCH, COLD-STORAGE SOLUTIONS IN KIDNEY TRANSPLANTATION
1993
EFFECTS OF MHC-ENCODED TAP1 AND TAP2 GENE POLYMORPHISM AND MATCHING ON KIDNEY GRAFT REJECTION
1995
DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1
1997
Salt Wastage, Plasma Volume Contraction and Hypokalemic Paralysis in Self-Induced Water Intoxication
1993
Recurrent Hematuria in 4 White Patients with Sickle Cell Trait
1984
High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients.
1994
[Expression of T-lymphocyte antigens by serum B lymphocytes in rheumatoid polyarthritis].
1986
BASILIXIMAB (SIMULECT®) IS SAFE AND EFFECTIVE IN COMBINATION WITH TRIPLE THERAPY OF NEORAL®, STEROIDS AND CELLCEPT® IN RENAL TRANSPLANT RECIPIENTS.
2000
Captopril induces correction of postrenal transplant erythremia
1990
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
2000
Renal failure in the course of reactivation of varicella-zoster virus infection in a renal transplant recipient
1986